NICE recommends new treatment options for blood cancer patients Pharmaceutical Field 12:13 Thu, 06 Aug
High SGK1 Expression Predicts Poor Outcomes After ASCT in Multiple Myeloma Hematology Advisor 15:27 Wed, 05 Aug
Enzomenib Receives FDA Orphan Drug Designation for Treatment of ALL Rare Disease Advisor 22:11 Tue, 04 Aug
Balancing Autonomy, Quality of Life, and Long-Term Planning in Multiple Myeloma Medpage Today 16:04 Tue, 04 Aug
Mental Distress, Fatigue Common in Childhood Survivors of Leukemia, Lymphoma Psychiatry Advisor 15:08 Tue, 04 Aug
Mum told knee pain was 'curable cancer' but gets huge blow weeks later Liverpool Echo 11:29 Tue, 04 Aug Article paywall
Mum cries 'my babies' after being told mystery leg pain was incurable cancer The Mirror 08:22 Tue, 04 Aug Article paywall
Vaxcellbio launches global co-development program for NRC-based NK cell therapy for multiple myeloma Korea Biomedical Review 07:23 Tue, 04 Aug
Bruce Springsteen's wife Patti, 73, gives health update eight years after blood cancer diagnosis MailOnline 05:54 Tue, 04 Aug Article paywall
Hidden DNA Changes May Predict Blood Cancer Years Before It Worsens Knowridge Science Report 18:59 Mon, 03 Aug
Medicare Advantage Linked With Lower Likelihood of Initiating Combination Therapy Against Myeloma Hematology Advisor 16:05 Mon, 03 Aug
Brother flies from New York to donate stem cells after rare blood cancer returns The Christie NHS Foundation Trust (Press Release) 11:32 Mon, 03 Aug
Boosting CGT access: a global consideration with wide-spanning benefits Pharmaceutical Technology 11:48 Fri, 31 Jul
More options, more questions in the management of early relapsed and/or refractory multiple myeloma Nature.com 11:20 Fri, 31 Jul
New drug coverage delays cut myeloma patients’ survival in Korea and Taiwan from Japan’s: study Korea Biomedical Review 06:08 Fri, 31 Jul
Indefinite-Duration Maintenance Therapy No Better Than Fixed-Duration Therapy in Multiple Myeloma Oncology Nurse Advisor 14:09 Thu, 30 Jul
New software helps researchers decode the cellular architecture of lymphoma ecancer 12:55 Thu, 30 Jul
Estrella activates new site in Texas for STARLIGHT-1 Phase I/II trial Clinical Trials Arena 10:49 Thu, 30 Jul
Disparities in Radiation Therapy Persist in Primary Bone DLBCL Rare Disease Advisor 20:27 Wed, 29 Jul
Sheffield Children’s consultants tackle Tour de France challenge to fund life-saving blood cancer research Sheffield Children's NHS Foundation Trust 18:16 Tue, 28 Jul
Inotuzumab Ozogamicin Shows Promise in Pediatric Very High-Risk First B-ALL Relapse Hematology Advisor 15:20 Tue, 28 Jul
AbbVie Korea's Epkinly gains expanded approval in relapsed or refractory follicular lymphoma Korea Biomedical Review 05:14 Tue, 28 Jul
Rare BTK mutation drives resistance to targeted therapies for blood cancer News-Medical.Net 03:35 Tue, 28 Jul
Definition of Functional High-Risk Multiple Myeloma Updated in Era of Combo Therapy Oncology Nurse Advisor 16:02 Mon, 27 Jul
Genetic makeup affects whether patients experience benefits or side effects of immune cell therapy for cancer ecancer 10:46 Mon, 27 Jul
Inherited genetics can influence safety and success of CAR-T cell therapy News-Medical.Net 20:15 Fri, 24 Jul
J&J’s multiple myeloma combo cuts risk of death by 62% in Phase III study Clinical Trials Arena 11:11 Fri, 24 Jul
Scientists Discover Clue That May Predict Aggressive Multiple Myeloma Knowridge Science Report 08:58 Fri, 24 Jul
Advanced regenerative therapies to be tested for liver cancer and lymphoma in Korea Korea Biomedical Review 08:48 Fri, 24 Jul
Doctors Now Can Spot the Most Dangerous Multiple Myeloma Earlier Knowridge Science Report 22:03 Thu, 23 Jul
Why Blood Cancer and Autoimmune Diseases Often Appear Together Knowridge Science Report 22:03 Thu, 23 Jul
Genmab and AbbVie Provide Clarification on Phase 3 EPCORE® DLBCL-1 Trial Evaluating Epcoritamab (DuoBody® CD3xCD20) in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL) AbbVie (Press Release) 21:11 Thu, 23 Jul
Doctors update the warning signs for the most dangerous multiple myeloma cases Knowridge Science Report 11:02 Thu, 23 Jul
SMC uncovers 'decoy' mechanism behind rituximab resistance in lymphoma Korea Biomedical Review 03:26 Thu, 23 Jul
